The trading price of 180 Life Sciences Corp. (NASDAQ:ATNF) closed higher on Tuesday, Jan 12, closing at $2.7, 7.04% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $2.5650 and $3.0250. The company’s P/E ratio in the trailing 12-month period was 0, while its 5Y monthly beta was 0. In examining the 52-week price action we see that the stock hit a 52-week high of $11.5 and a 52-week low of $1.9. Over the past month, the stock has gained 10.73% in value.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of 180 Life Sciences Corp. no upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest ATNF has a 50% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
To see how 180 Life Sciences Corp. stock has been performing in comparison to its peers in the industry, here are the numbers: ATNF stock’s performance was +7.04% in the latest trading, and -71.5% in the past year, while Bristol-Myers Squibb Company (BMY) has traded +0.71% on the day and positioned -1.09% lower than it was a year ago. Another comparable company Amgen Inc (AMGN) saw its stock close -0.41% lower in the most recent trading session but was down -0.14% in a year. Furthermore, Gilead Sciences Inc (GILD) showed an increase of 7.04% on the day while its price kept declining at -71.5% over the past year. 180 Life Sciences Corp. has a P/E ratio of 0, compared to Bristol-Myers Squibb Company’s 0 and Amgen Inc’s 19.08. Also in last trading session, the S&P 500 Index has surged 0.04%, while the Dow Jones Industrial also saw a positive session, up +0.19% on the day.
An evaluation of the daily trading volume of 180 Life Sciences Corp. (NASDAQ:ATNF) indicates that the 3-month average is 1.12 Million. However, this figure has increased over the past 10 days to an average of 726.48 Million.
Currently, records show that 21.17 Million of the company’s shares remain outstanding. According to Thomson Reuters data, insiders hold 57.18% of outstanding shares, whereas institutions hold 4.81%. The stats also highlight that short interest as of December 14, 2020, stood at 23.71 Million shares, resulting in a short ratio of 0.04 at that time. From this, we can conclude that short interest is 0.13% of the company’s total outstanding shares. It is noteworthy that short shares in December were up slightly from the previous month’s figure, which was 8.25 Million. However, since the stock’s price has seen +5.86% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
Even if you’re not actively in crypto, you deserve to know what’s actually going on..
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets are already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.